• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于学生节日活动中的疫情对新冠病毒突破性感染进行风险分层

Risk Stratification of SARS-CoV-2 Breakthrough Infections Based on an Outbreak at a Student Festive Event.

作者信息

Bertram Ralph, Bartsch Vanessa, Sodmann Johanna, Hennig Luca, Müjde Engin, Stock Jonathan, Ruedig Vivienne, Sodmann Philipp, Todt Daniel, Steinmann Eike, Hitzl Wolfgang, Steinmann Joerg

机构信息

Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Klinikum Nürnberg, Paracelsus Medical University, 90419 Nuremberg, Germany.

Study Program in Human Medicine, Paracelsus Medical University, 90419 Nuremberg, Germany.

出版信息

Vaccines (Basel). 2022 Mar 11;10(3):432. doi: 10.3390/vaccines10030432.

DOI:10.3390/vaccines10030432
PMID:35335064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8950301/
Abstract

In early 2022, the Coronavirus disease 2019 (COVID-19) remains a global challenge. COVID-19 is caused by an increasing number of variants of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Here, we report an outbreak of SARS-CoV-2 breakthrough infections related to a student festive event with 100 mostly vaccinated guests, which took place in Northern Bavaria, Germany, in October 2021. The data were obtained by retrospective guest interviews. In total, 95 students participated in the study, with 94 being fully vaccinated and 24 reporting infection by the delta variant. Correlation analyses among 15 examined variables revealed that time spent at the event, conversation with the supposed index person, and a homologous viral vector vaccination regime were significant risk factors for infection. Non-significant observations related to higher rates of infection included time since last vaccination, shared use of drinking vessels, and number of individual person-to-person contacts at the event. Our data suggest that a high rate of breakthrough infections with the delta variant occurs if no preventive measures are practiced. To limit infection risk, high-quality testing of participants should be considered a mandatory measure at gatherings, irrespective of the participants' vaccination status.

摘要

2022年初,2019冠状病毒病(COVID-19)仍是一项全球挑战。COVID-19由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)越来越多的变种引起。在此,我们报告了一起与一场学生节日活动相关的SARS-CoV-2突破性感染疫情,该活动于2021年10月在德国巴伐利亚州北部举行,有100名大多已接种疫苗的宾客参加。数据通过对宾客的回顾性访谈获得。共有95名学生参与了研究,其中94人已完全接种疫苗,24人报告感染了德尔塔变种。对15个检测变量的相关性分析显示,在活动中停留的时间、与假定的索引病例的交谈以及同源病毒载体疫苗接种方案是感染的重要风险因素。与较高感染率相关的无统计学意义的观察结果包括上次接种疫苗后的时间、共用饮水容器以及活动中个人之间的接触次数。我们的数据表明,如果不采取预防措施,德尔塔变种的突破性感染率会很高。为了限制感染风险,无论参与者的疫苗接种状况如何,都应考虑对参与者进行高质量检测作为聚会的一项强制性措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/2b3d768a1da9/vaccines-10-00432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/b741d354a453/vaccines-10-00432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/f6339f537ef0/vaccines-10-00432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/3220213df835/vaccines-10-00432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/2b3d768a1da9/vaccines-10-00432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/b741d354a453/vaccines-10-00432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/f6339f537ef0/vaccines-10-00432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/3220213df835/vaccines-10-00432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be4/8950301/2b3d768a1da9/vaccines-10-00432-g004.jpg

相似文献

1
Risk Stratification of SARS-CoV-2 Breakthrough Infections Based on an Outbreak at a Student Festive Event.基于学生节日活动中的疫情对新冠病毒突破性感染进行风险分层
Vaccines (Basel). 2022 Mar 11;10(3):432. doi: 10.3390/vaccines10030432.
2
An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.一起德尔塔变异株引起的精神科封闭病房突破性感染事件
J Korean Med Sci. 2022 Jan 24;37(4):e28. doi: 10.3346/jkms.2022.37.e28.
3
Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.新冠病毒疫苗在预防已接种德尔塔和阿尔法变异株感染者突破性感染中的比较效果。
Emerg Infect Dis. 2022 Feb;28(2):331-337. doi: 10.3201/eid2802.211789. Epub 2021 Dec 7.
4
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.2021 年 7 月,马萨诸塞州巴恩斯特布尔县与大型公众集会相关的 SARS-CoV-2 感染暴发,包括 COVID-19 疫苗突破性感染。
MMWR Morb Mortal Wkly Rep. 2021 Aug 6;70(31):1059-1062. doi: 10.15585/mmwr.mm7031e2.
5
Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota.明尼苏达州室内婚礼接待会上,接种疫苗和未接种疫苗的与会者之间 COVID-19 的传播和感染。
JAMA Netw Open. 2022 Feb 1;5(2):e220536. doi: 10.1001/jamanetworkopen.2022.0536.
6
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
7
Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China.中国东部公交车乘客中 SARS-CoV-2 传播的社区暴发调查。
JAMA Intern Med. 2020 Dec 1;180(12):1665-1671. doi: 10.1001/jamainternmed.2020.5225.
8
Rapid Control of a SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Community Outbreak: The Successful Experience in Pingtung County of Taiwan.快速控制严重急性呼吸综合征冠状病毒2型B.1.617.2(德尔塔)变异株新型冠状病毒肺炎社区疫情:台湾屏东县的成功经验
Int J Environ Res Public Health. 2022 Jan 27;19(3):1421. doi: 10.3390/ijerph19031421.
9
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021.2021 年 7 月至 8 月,德克萨斯州一联邦监狱中被监禁人员感染 SARS-CoV-2 B.1.617.2(Delta)变异株疫情。
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1349-1354. doi: 10.15585/mmwr.mm7038e3.
10
Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office.呼吸道合并感染是否会促进 SARS-CoV-2 的传播?对开放式办公场所超级传播事件的调查。
Antimicrob Resist Infect Control. 2020 Dec 2;9(1):191. doi: 10.1186/s13756-020-00861-z.

引用本文的文献

1
COVID-19 Breakthrough Infections among Medical Students under the SLICE and CLARO Programs: Ateneo School of Medicine and Public Health Experience.SLICE和CLARO项目下医学生中的COVID-19突破性感染:雅典耀医学院和公共卫生学院的经验
Acta Med Philipp. 2024 Jan 26;58(1):34-41. doi: 10.47895/amp.vi0.6523. eCollection 2024.

本文引用的文献

1
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence.黏膜疫苗、灭菌免疫与SARS-CoV-2毒力的未来
Viruses. 2022 Jan 19;14(2):187. doi: 10.3390/v14020187.
2
Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?意大利南部接种过加强针(3剂)的医护人员中出现的新冠病毒奥密克戎变异株本土疫情:只是冰山一角?
Vaccines (Basel). 2022 Feb 13;10(2):283. doi: 10.3390/vaccines10020283.
3
Post-Vaccination SARS-CoV-2 Infections among Health Workers at the University Hospital of Verona, Italy: A Retrospective Cohort Survey.
意大利维罗纳大学医院医护人员接种新冠疫苗后的感染情况:一项回顾性队列研究
Vaccines (Basel). 2022 Feb 10;10(2):272. doi: 10.3390/vaccines10020272.
4
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.第二剂 COVID-19 疫苗接种后 9 个月内的感染、住院和死亡风险:瑞典的一项回顾性、全人群队列研究。
Lancet. 2022 Feb 26;399(10327):814-823. doi: 10.1016/S0140-6736(22)00089-7. Epub 2022 Feb 4.
5
What do we know about covid vaccines and preventing transmission?关于新冠疫苗及预防传播,我们了解些什么?
BMJ. 2022 Feb 4;376:o298. doi: 10.1136/bmj.o298.
6
GISAID's Role in Pandemic Response.全球流感共享数据库(GISAID)在大流行应对中的作用。
China CDC Wkly. 2021 Dec 3;3(49):1049-1051. doi: 10.46234/ccdcw2021.255.
7
Assessing the efficacy of interventions to control indoor SARS-Cov-2 transmission: An agent-based modeling approach.评估控制室内新冠病毒传播干预措施的效果:基于主体的建模方法。
Epidemics. 2021 Dec;37:100524. doi: 10.1016/j.epidem.2021.100524. Epub 2021 Nov 12.
8
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.BNT162b2 mRNA COVID-19 疫苗加强针在预防以色列重症结局的有效性:一项观察性研究。
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.
9
Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株(B.1.617.2)相关的2019冠状病毒病病例的家庭传播:全国病例对照研究
Lancet Reg Health Eur. 2022 Jan;12:100252. doi: 10.1016/j.lanepe.2021.100252. Epub 2021 Oct 28.
10
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021.2021 年 7 月,在高疫苗接种人群中,由 SARS-CoV-2 Delta 变异株引起的医院感染暴发。以色列。
Euro Surveill. 2021 Sep;26(39). doi: 10.2807/1560-7917.ES.2021.26.39.2100822.